Mediwound Ltd Ord Sh (MDWD) Stock Price, Quote & News

Company Profile

MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States, Germany, Italy, Spain, and internationally. The company markets NexoBrid, a biopharmaceutical product for the removal of eschar in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. It also develops EscharEx, a bromelain-based, bioactive enzymatic ther...

Industry: Biotechnology

Sector: Healthcare

Phone: 972 7 797 14100

Website: www.mediwound.com

Address:

42 Hayarkon Street, Yavne, Israel

Estimize Aug. 19 at 10:00 AM

Wall St is expecting -0.87 EPS for $MDWD Q3 [Reporting 11/17 BMO] http://www.estimize.com/intro/mdwd?chart=historical&metric_name=eps&utm_c

0 · Reply

novelty Aug. 17 at 11:38 PM

$MDWD no support til 8 bucks

0 · Reply

novelty Aug. 17 at 8:30 PM

$MDWD won’t be long now til 9$ stonk then 8-8-6-5-4-3-2-1-000000zeeeero

0 · Reply

novelty Aug. 17 at 2:35 PM

$MDWD do I still see big fat dicks or are those just big fat wicks. 9.99$$

0 · Reply

novelty Aug. 16 at 11:00 PM

$MDWD where’s our pumper at

0 · Reply

novelty Aug. 14 at 1:50 PM

$MDWD ROFL

0 · Reply

novelty Aug. 14 at 1:47 PM

$MDWD this thing is down this hard while markets r flying. Now wait til the market gets smashed into September and October wonder what happens here 👀 8.99$ stonk

0 · Reply

novelty Aug. 14 at 1:44 PM

$MDWD do u guys wake Up In the morning and think man maybe today we will get a green candle without a big fat selling wick.

0 · Reply

novelty Aug. 13 at 8:47 PM

$MDWD just a disgusting chart in the middle Of the biggest bull market ever

0 · Reply

enalpa Aug. 13 at 7:19 PM

$MDWD another presentation and another negative response from wall st.

1 · Reply

MediWound reports Q2 EPS ($1.36), consensus (77c)

2026-08-17T07:54:41.000Z - 2 days ago

MediWound backs FY26 revenue view $24M-$26M, consensus $24.13M

2026-08-16T13:29:47.000Z - 3 days ago

MediWound price target lowered to $30 from $32 at Oppenheimer

Aug 13, 2026, 8:30 AM EDT - 6 days ago

MediWound Earnings Call Transcript: Q2 2026

Aug 13, 2026, 8:30 AM EDT - 6 days ago

MediWound Earnings release: Q2 2026

Aug 13, 2026, 8:00 AM EDT - 6 days ago

MediWound Slides: Corporate presentation

Aug 13, 2026, 7:00 AM EDT - 6 days ago

MediWound Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Jul 29, 2026, 8:00 AM EDT - 21 days ago

MediWound to Report Second Quarter 2026 Financial Results

2026-05-28T21:35:50.000Z - 2 months ago

MediWound price target lowered to $22 from $25 at Alliance Global

2026-05-28T15:33:26.000Z - 2 months ago

MediWound price target lowered to $32 from $33 at Oppenheimer

May 27, 2026, 8:30 AM EDT - 3 months ago

MediWound Earnings Call Transcript: Q1 2026

May 27, 2026, 8:30 AM EDT - 3 months ago

MediWound Earnings release: Q1 2026

2026-05-27T11:14:53.000Z - 3 months ago

MediWound reports Q1 EPS (23c), consensus (66c)

May 27, 2026, 7:00 AM EDT - 3 months ago

MediWound Reports First Quarter 2026 Financial Results and Provides Corporate Update

MDLN

May 26, 2026, 7:00 AM EDT - 3 months ago

MediWound Slides: Corporate presentation

May 7, 2026, 8:00 AM EDT - 3 months ago

MediWound to Report First Quarter 2026 Financial Results

Apr 13, 2026, 7:30 AM EDT - 4 months ago

Newly Published U.S. Expert Consensus Aligns with MediWound's Strategy for Chronic Wound Debridement

Apr 7, 2026, 7:00 AM EDT - 4 months ago

MediWound to Present New EscharEx® Data at Leading Wound Care Conferences

2026-04-02T19:37:47.000Z - 4 months ago

MediWound says Vericel awarded ten-year contract valued at up to $197M

VCEL

Apr 2, 2026, 3:26 PM EDT - 4 months ago

MediWound Reports BARDA Contract Award to Vericel for NexoBrid® Valued at up to $197 Million

2026-03-12T16:05:24.000Z - 5 months ago

MediWound management to meet with Maxim

Mar 5, 2026, 4:30 PM EST - 5 months ago

MediWound Files Annual Report on Form 20-F

Mar 5, 2026, 8:30 AM EST - 5 months ago

MediWound Earnings Call Transcript: Q4 2025

Mar 5, 2026, 8:30 AM EST - 5 months ago

MediWound Annual report: Q4 2025

Mar 5, 2026, 8:30 AM EST - 5 months ago

MediWound Earnings release: Q4 2025

2026-03-05T12:15:32.000Z - 5 months ago

MediWound reports Q4 EPS (56c), consensus (61c)

2026-03-05T12:14:40.000Z - 5 months ago

MediWound sees FY26 revenue $24M-$26M, consensus $26.21M

2026-03-05T12:14:25.000Z - 5 months ago

MediWound sees FY27 revenue $32M-$35M, sees FY28 revenue $50M-$55M

Mar 5, 2026, 7:00 AM EST - 5 months ago

MediWound Reports Fourth Quarter and Full Year 2025 Financial Results

2026-03-03T15:01:53.000Z - 6 months ago

MediWound management to meet with Maxim

Mar 3, 2026, 7:00 AM EST - 6 months ago

MediWound Slides: Corporate presentation

Mar 2, 2026, 1:10 PM EST - 6 months ago

MediWound Transcript: TD Cowen 46th Annual Health Care Conference

Feb 26, 2026, 10:40 AM EST - 6 months ago

MediWound Transcript: Oppenheimer 36th Annual Healthcare Life Sciences Conference

Feb 19, 2026, 8:00 AM EST - 6 months ago

MediWound to Report Fourth Quarter and Full Year 2025 Financial Results

Feb 17, 2026, 8:00 AM EST - 6 months ago

MediWound to Present at Upcoming Investor Conferences

2026-01-12T12:06:19.000Z - 7 months ago

MediWound sees FY25 revenue $17M, consensus $22.98M

2026-01-12T12:05:27.000Z - 7 months ago

MediWound sees FY26 revenue $24-26M, consensus $28.8M

Jan 12, 2026, 7:00 AM EST - 7 months ago

MediWound Provides Corporate Update and Financial Outlook Ahead of the J.P. Morgan Healthcare Conference

2025-12-10T12:10:37.000Z - 9 months ago

MediWound reports clinical data on NexoBrid’s effectiveness

Dec 10, 2025, 7:00 AM EST - 9 months ago

MediWound Reports New Clinical Data Demonstrating NexoBrid®'s Effectiveness in Preventing Traumatic Tattoos After Abrasion and Blast Injuries

2025-11-21T11:10:36.000Z - 9 months ago

MediWound price target raised to $36 from $31 at H.C. Wainwright

Nov 20, 2025, 8:30 AM EST - 9 months ago

MediWound Earnings Call Transcript: Q3 2025

Nov 20, 2025, 8:30 AM EST - 9 months ago

MediWound Earnings release: Q3 2025

2025-11-20T12:06:10.000Z - 9 months ago

MediWound reports Q3 EPS (24c), consensus (98c)

Nov 20, 2025, 7:00 AM EST - 9 months ago

MediWound Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Nov 20, 2025, 7:00 AM EST - 9 months ago

MediWound Slides: Corporate Presentation

Nov 5, 2025, 7:30 AM EST - 10 months ago

MediWound to Report Third Quarter 2025 Financial Results

2025-11-03T13:20:37.000Z - 10 months ago

MediWound completes commissioning of expanded GMP manufacturing facility

Nov 3, 2025, 8:00 AM EST - 10 months ago

MediWound Successfully Completes Commissioning of Expanded GMP Manufacturing Facility for NexoBrid®

2025-09-29T12:45:46.000Z - 11 months ago

MediWound announces $30M registered direct offering

2025-09-29T12:45:35.000Z - 11 months ago

MediWound down 8% at $16.50 following offering

Sep 29, 2025, 8:37 AM EDT - 11 months ago

MediWound Announces $30 Million Registered Direct Offering of Ordinary Shares

Sep 25, 2025, 7:30 AM EDT - 11 months ago

MediWound Expands Global Reach with Marketing Approval of NexoBrid® in Australia

Sep 8, 2025, 4:30 PM EDT - 1 year ago

MediWound Transcript: H.C. Wainwright 27th Annual Global Investment Conference

Sep 2, 2025, 7:30 AM EDT - 1 year ago

MediWound's NexoBrid® to be Highlighted in 36 Scientific Presentations at the 21st European Burns Association Congress

Aug 20, 2025, 7:30 AM EDT - 1 year ago

MediWound to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Aug 14, 2025, 8:30 AM EDT - 1 year ago

MediWound Earnings Call Transcript: Q2 2025

Aug 14, 2025, 8:30 AM EDT - 1 year ago

MediWound Earnings release: Q2 2025

Aug 14, 2025, 7:00 AM EDT - 1 year ago

MediWound Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Aug 13, 2025, 8:45 AM EDT - 1 year ago

MediWound Announces New EscharEx® Phase II Data Demonstrating Strong Link Between Wound Bed Preparation and Wound Closure in Venous Leg Ulcers

Aug 4, 2025, 7:30 AM EDT - 1 year ago

MediWound to Report Second Quarter 2025 Financial Results

May 21, 2025, 8:30 AM EDT - 1 year ago

MediWound Earnings Call Transcript: Q1 2025

May 21, 2025, 8:30 AM EDT - 1 year ago

MediWound Earnings release: Q1 2025

May 21, 2025, 7:00 AM EDT - 1 year ago

MediWound Reports First Quarter 2025 Financial Results and Provides Corporate Update

May 13, 2025, 7:30 AM EDT - 1 year ago

MediWound Announces Publication of Phase II EscharEx® Data Demonstrating Superiority Over Collagenase in Venous Leg Ulcers

May 5, 2025, 8:00 AM EDT - 1 year ago

MediWound to Report First Quarter 2025 Financial Results

Mar 19, 2025, 8:30 AM EDT - 1 year ago

MediWound Earnings Call Transcript: Q4 2024

Mar 19, 2025, 8:30 AM EDT - 1 year ago

MediWound Annual report: Q4 2024

Mar 19, 2025, 8:30 AM EDT - 1 year ago

MediWound Earnings release: Q4 2024

Mar 19, 2025, 8:00 AM EDT - 1 year ago

MediWound Registration statement: Registration Filing

Mar 19, 2025, 7:00 AM EDT - 1 year ago

MediWound Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

Mar 5, 2025, 11:50 AM EST - 1 year ago

MediWound Transcript: TD Cowen 45th Annual Healthcare Conference

Mar 3, 2025, 8:00 AM EST - 1 year ago

MediWound to Report Fourth Quarter and Full Year 2024 Financial Results

Feb 25, 2025, 8:00 AM EST - 1 year ago

MediWound Announces Phase III CIDS Publication on NexoBrid® for Pediatric Burn Care

Feb 24, 2025, 8:00 AM EST - 1 year ago

MediWound to Present at the 45th Annual TD Cowen Health Care Conference

Feb 12, 2025, 8:12 AM EST - 1 year ago

MediWound to launch Phase III trial for venous leg ulcers

Feb 12, 2025, 8:00 AM EST - 1 year ago

MediWound Transcript: Oppenheimer 35th Annual Healthcare Life Sciences Conference (Virtual) 2025

Feb 12, 2025, 7:00 AM EST - 1 year ago

MediWound Initiates the VALUE Global Phase III Pivotal Trial of EscharEx® for Treatment of Venous Leg Ulcers

Nov 26, 2024, 8:30 AM EST - 1 year ago

MediWound Earnings Call Transcript: Q3 2024

Nov 26, 2024, 8:30 AM EST - 1 year ago

MediWound Earnings release: Q3 2024

Nov 26, 2024, 7:00 AM EST - 1 year ago

MediWound Reports Third Quarter 2024 Financial Results and Provides Company Update

Oct 10, 2024, 7:00 AM EDT - 2 years ago

MediWound Announces Phase II Head-to-Head Study Evaluating EscharEx® vs. Collagenase in Patients with Venous Leg Ulcers

Sep 10, 2024, 3:30 PM EDT - 2 years ago

MediWound Transcript: H.C. Wainwright 26th Annual Global Investment Conference 2024

Aug 29, 2024, 8:00 AM EDT - 2 years ago

MediWound Registration statement: Registration Filing

Aug 15, 2024, 4:15 PM EDT - 2 years ago

MediWound Announces U.S. Food and Drug Administration Approval of NexoBrid® for the Treatment of Pediatric Patients with Severe Thermal Burns

Aug 14, 2024, 8:30 AM EDT - 2 years ago

MediWound Earnings Call Transcript: Q2 2024

Aug 14, 2024, 8:30 AM EDT - 2 years ago

MediWound Earnings release: Q2 2024

Aug 14, 2024, 7:00 AM EDT - 2 years ago

MediWound Reports Second Quarter 2024 Financial Results and Provides Company Update

Aug 5, 2024, 7:30 AM EDT - 2 years ago

MediWound Announces Positive Results from the U.S. NexoBrid® Expanded Access Protocol (NEXT)

Aug 2, 2024, 8:00 AM EDT - 2 years ago

MediWound to Report Second Quarter 2024 Financial Results

Jul 29, 2024, 8:00 AM EDT - 2 years ago

MediWound Announces Publication of the EscharEx® Phase II ChronEx Study Results for Venous Leg Ulcers

Jul 16, 2024, 7:30 AM EDT - 2 years ago

MediWound Announces €16.25 Million Funding from the European Innovation Council Accelerator Program

Jul 15, 2024, 7:32 AM EDT - 2 years ago

Mölnlycke® Health Care announces US $15m investment in next-generation enzymatic therapeutics company MediWound Ltd

Jul 15, 2024, 7:00 AM EDT - 2 years ago

MediWound Announces $25 Million Strategic Private Placement Financing

Jun 3, 2024, 10:34 AM EDT - 2 years ago

MediWound Earnings Call Transcript: Q1 2024

Jun 3, 2024, 10:34 AM EDT - 2 years ago

MediWound Earnings release: Q1 2024

May 29, 2024, 7:00 AM EDT - 2 years ago

MediWound Reports First Quarter 2024 Financial Results and Provides Company Update

May 22, 2024, 8:00 AM EDT - 2 years ago

MediWound to Report First Quarter 2024 Financial Results

Apr 25, 2024, 8:00 AM EDT - 2 years ago

MediWound to Present New Data from EscharEx® Phase II Studies at Three Leading Wound Care Conferences

Mar 21, 2024, 8:30 AM EDT - 2 years ago

MediWound Earnings Call Transcript: Q4 2023

Mar 21, 2024, 8:30 AM EDT - 2 years ago

MediWound Annual report: Q4 2023

Mar 21, 2024, 8:30 AM EDT - 2 years ago

MediWound Earnings release: Q4 2023

Mar 21, 2024, 7:00 AM EDT - 2 years ago

MediWound Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update

Mar 14, 2024, 8:00 AM EDT - 2 years ago

MediWound to Report Fourth Quarter and Full Year 2023 Financial Results

Feb 12, 2024, 7:00 AM EST - 2 years ago

MediWound Announces Positive Results in Head-to-Head Comparison of EscharEx® vs. SANTYL® within the ChronEx Phase II Randomized Controlled Study

Feb 5, 2024, 8:00 AM EST - 2 years ago

MediWound to Participate in Two Upcoming Investor Conferences

Jan 9, 2024, 7:00 AM EST - 2 years ago

MediWound Announces that FDA has Accepted for Review the Supplement to the NexoBrid BLA to Include Pediatric Patients with Severe Thermal Burns

Estimize Aug. 19 at 10:00 AM

Wall St is expecting -0.87 EPS for $MDWD Q3 [Reporting 11/17 BMO] http://www.estimize.com/intro/mdwd?chart=historical&metric_name=eps&utm_c

0 · Reply

novelty Aug. 17 at 11:38 PM

$MDWD no support til 8 bucks

0 · Reply

novelty Aug. 17 at 8:30 PM

$MDWD won’t be long now til 9$ stonk then 8-8-6-5-4-3-2-1-000000zeeeero

0 · Reply

novelty Aug. 17 at 2:35 PM

$MDWD do I still see big fat dicks or are those just big fat wicks. 9.99$$

0 · Reply

novelty Aug. 16 at 11:00 PM

$MDWD where’s our pumper at

0 · Reply

novelty Aug. 14 at 1:50 PM

$MDWD ROFL

0 · Reply

novelty Aug. 14 at 1:47 PM

$MDWD this thing is down this hard while markets r flying. Now wait til the market gets smashed into September and October wonder what happens here 👀 8.99$ stonk

0 · Reply

novelty Aug. 14 at 1:44 PM

$MDWD do u guys wake Up In the morning and think man maybe today we will get a green candle without a big fat selling wick.

0 · Reply

novelty Aug. 13 at 8:47 PM

$MDWD just a disgusting chart in the middle Of the biggest bull market ever

0 · Reply

enalpa Aug. 13 at 7:19 PM

$MDWD another presentation and another negative response from wall st.

1 · Reply

novelty Aug. 13 at 5:55 PM

$MDWD this will be shorted for the next two years. Have fun. Short every pop to make money

0 · Reply

novelty Aug. 13 at 5:33 PM

$MDWD last chance off the sinking ship before single digits

0 · Reply

Its_Only_Money_369 Aug. 13 at 4:00 PM

$MDWD Well, at this rate 38 days may be a little excessive. 🤔

1 · Reply

Its_Only_Money_369 Aug. 13 at 3:13 PM

$MDWD 38 days to cover

0 · Reply

JohnPDaly Aug. 13 at 1:55 PM

$MDWD last quarter before the Algos take over.

0 · Reply

z06forum Aug. 13 at 1:43 PM

$MDWD new peak sales re rate Scenario Peak-sales multiple Implied value Conservative 2.0× $2.1B Reasonable 3.0× $3.15B Strategic 4.0× $4.2B Aggressive 5.0× $5.25B

0 · Reply

novelty Aug. 13 at 1:02 PM

$MDWD 2M a quarter how is this gonna even come close to 20M this year rofl Does management just continue to lie?

0 · Reply

BruceZee Aug. 13 at 12:44 PM

$MDWD Did the expected timing for regulatory approval of the new facility slip?

0 · Reply

StocktwitsEarnings Aug. 13 at 12:10 PM

$MDWD Q2 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.57 up 53.66% YoY • Reported revenue of $3.09M down -45.83% YoY • MediWound reaffirmed its full-year 2026 revenue guidance of $2426 million, which is supported by expected second-half contributions from the Master Services Agreement and other government-funded programs for MediWound.

0 · Reply

JohnPDaly Aug. 13 at 11:55 AM

$MDWD The Company reaffirmed its full-year 2026 revenue guidance of $24–26 million, supported by expected second-half contributions from the MSA and other government-funded programs.

0 · Reply

JohnPDaly Aug. 13 at 11:20 AM

$MDWD https://ir.mediwound.com/news-releases/news-release-details/mediwound-reports-second-quarter-2026-financial-results-and

0 · Reply

Estimize Aug. 13 at 10:01 AM

$MDWD reported - EPS and - revenue for Q2. http://www.estimize.com/intro/mdwd?chart=historical&metric_name=eps&utm_content=MDWD&utm_medium=

0 · Reply

Market Cap	172.09M
Revenue (ttm)	16.96M
Net Income (ttm)	-23.88M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-140.80%
Debt to Equity Ratio	0.00

Volume	56,400
Avg Vol	75,934
Day's Range	N/A - N/A
Shares Out	12.85M
Stochastic %K	27%
Beta	0.15
Analysts	Strong Sell
Price Target	$29.83